ABPI position on biosimilar medicines

Publication date:  14/05/2014
Publication ref: 
To support its members, the ABPI has updated its position paper on biosimilar medicines which cover areas where action is needed by regulators, HTA agencies, NHS commissioners and NHS healthcare professionals who prescribe or dispense biosimilar medicines.

Document size: 79KB

Print this page icon Print this page
Please choose the subject of your enquiry from the list below:
Code to enter for submitting the form
Enter the above code here:
Can't read? Try different words.